Information Provided By: 
Fly News Breaks for February 7, 2020
CI
Feb 7, 2020 | 09:31 EDT
SunTrust analyst David MacDonald raised his price target on Cigna to $280 and kept his Buy rating after its Q4 results, saying the quarter saw "attractive core trends" with an MCR beat and superb cash flows. The analyst also notes the company's "solid momentum" across its business lines while benefiting from "attractive" medical and drug cost trends. MacDonald adds that Cigna's meaningful and growing balance sheet optionality may potentially represent an underappreciated asset.
News For CI From the Last 2 Days
There are no results for your query CI
